{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:10:40Z","timestamp":1789989040195,"version":"4.0.1"},"reference-count":42,"publisher":"Society of Nuclear Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.2967\/jnumed.118.224543","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T02:15:28Z","timestamp":1552097728000},"page":"1359-1365","source":"Crossref","is-referenced-by-count":32,"title":["Intention-to-Treat Analysis of <sup>68<\/sup>Ga-PSMA and <sup>11<\/sup>C-Choline PET\/CT Versus CT for Prostate Cancer Recurrence After Surgery"],"prefix":"10.2967","volume":"60","author":[{"given":"Johannes","family":"Schwenck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann-Cathrin","family":"Olthof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pfannenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Reischl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Marzec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Bedke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"la Foug\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt-Christian","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"2021051712135180000_60.10.1359.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)63946-8"},{"key":"2021051712135180000_60.10.1359.2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ncpuro0145","article-title":"Rising prostate-specific antigen after primary prostate cancer therapy","volume":"2","author":"Ward","year":"2005","journal-title":"Nat Clin Pract Urol."},{"key":"2021051712135180000_60.10.1359.3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.9607"},{"key":"2021051712135180000_60.10.1359.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.23.2760"},{"key":"2021051712135180000_60.10.1359.5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.9647"},{"key":"2021051712135180000_60.10.1359.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00111-X"},{"key":"2021051712135180000_60.10.1359.7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1607529","article-title":"Radiation with or without antiandrogen therapy in recurrent prostate cancer","volume":"376","author":"Shipley","year":"2017","journal-title":"N Engl J Med."},{"key":"2021051712135180000_60.10.1359.8","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.ijrobp.2011.09.039","article-title":"Postoperative radiotherapy in prostate cancer: the case of the missing target","volume":"83","author":"Croke","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2021051712135180000_60.10.1359.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.1.8"},{"key":"2021051712135180000_60.10.1359.10","unstructured":"NCCN guidelines. NCCN website. https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx. Accessed April 30, 2019. 2018:1\u2013129."},{"key":"2021051712135180000_60.10.1359.11","unstructured":"Interdisciplinary guideline on quality S3 for the early detection, diagnosis and treatment of the various stages of prostate cancer: version 5.0 [in German]. Leitlinienprogramm Onkologie website. https:\/\/www.leitlinienprogramm-onkologie.de\/fileadmin\/user_upload\/Downloads\/Leitlinien\/Prostata_5_0\/LL_Prostata_Langversion_5.0.pdf. Published April 2018. Accessed April 30, 2019."},{"key":"2021051712135180000_60.10.1359.12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.eururo.2016.08.002","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer","volume":"71","author":"Cornford","year":"2017","journal-title":"Eur Urol."},{"key":"2021051712135180000_60.10.1359.13","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol."},{"key":"2021051712135180000_60.10.1359.14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-018-4066-4","article-title":"68Ga-PSMA-11 PET\/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng\/ml: efficacy and impact on treatment strategy","volume":"46","author":"Farolfi","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712135180000_60.10.1359.15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00117-017-0276-1","article-title":"PET-CT and PET-MRI of the prostate: from 18F-FDG to 68Ga-PSMA [in German]","volume":"57","author":"Knorr","year":"2017","journal-title":"Radiologe."},{"key":"2021051712135180000_60.10.1359.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.11.008"},{"key":"2021051712135180000_60.10.1359.17","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.167.6.8956585"},{"key":"2021051712135180000_60.10.1359.18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00259-016-3490-6","article-title":"Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET\/CT","volume":"44","author":"Schwenck","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712135180000_60.10.1359.19","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.07.2011"},{"key":"2021051712135180000_60.10.1359.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.198119"},{"key":"2021051712135180000_60.10.1359.21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13550-016-0233-4","article-title":"Impact of 68Ga-PSMA PET\/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy","volume":"6","author":"Bluemel","year":"2016","journal-title":"EJNMMI Res."},{"key":"2021051712135180000_60.10.1359.22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00066-012-0169-1","article-title":"Toxicity and outcome of pelvic IMRT for node-positive prostate cancer","volume":"188","author":"M\u00fcller","year":"2012","journal-title":"Strahlenther Onkol."},{"key":"2021051712135180000_60.10.1359.23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2407-14-20","article-title":"Helical intensity-modulated radiotherapy of the pelvic lymph nodes with integrated boost to the prostate bed: initial results of the PLATIN 3 trial","volume":"14","author":"Katayama","year":"2014","journal-title":"BMC Cancer."},{"key":"2021051712135180000_60.10.1359.24","unstructured":"Rote Liste website home page. www.online.rote-liste.de. Drug information updated December 2018; prices updated February 15, 2019. Accessed April 30, 2019."},{"key":"2021051712135180000_60.10.1359.25","first-page":"103","article-title":"Summarising the effects of therapy: a new table and some more terms","volume":"2","author":"Sackett","year":"1997","journal-title":"Evid Based Med."},{"key":"2021051712135180000_60.10.1359.26","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.euf.2016.11.002","article-title":"68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography for prostate cancer: a systematic review and meta-analysis","volume":"4","author":"von Eyben","year":"2018","journal-title":"Eur Urol Focus."},{"key":"2021051712135180000_60.10.1359.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.192625"},{"key":"2021051712135180000_60.10.1359.28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.purol.2017.04.004","article-title":"PET\/CT and biochemical recurrence of prostate adenocarcinoma: added value of 68Ga-PSMA-11 when 18F-fluorocholine is non-contributive [in French]","volume":"27","author":"Gauth\u00e9","year":"2017","journal-title":"Prog Urol."},{"key":"2021051712135180000_60.10.1359.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.192476"},{"key":"2021051712135180000_60.10.1359.30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00259-017-3818-x","article-title":"Clinical impact of PSMA-based 18F-DCFBC PET\/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy","volume":"45","author":"Mena","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712135180000_60.10.1359.31","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-015-0548-8"},{"key":"2021051712135180000_60.10.1359.32","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000040"},{"key":"2021051712135180000_60.10.1359.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2872-x"},{"key":"2021051712135180000_60.10.1359.34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/COC.0000000000000139","article-title":"Does choline PET\/CT change the management of prostate cancer patients with biochemical failure?","volume":"40","author":"Goldstein","year":"2017","journal-title":"Am J Clin Oncol."},{"key":"2021051712135180000_60.10.1359.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2005.12.007"},{"key":"2021051712135180000_60.10.1359.36","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.2017.75.3657","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial","volume":"36","author":"Kyriakopoulos","year":"2018","journal-title":"J Clin Oncol."},{"key":"2021051712135180000_60.10.1359.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.07.060"},{"key":"2021051712135180000_60.10.1359.38","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70510-7"},{"key":"2021051712135180000_60.10.1359.39","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00066-012-0084-5","article-title":"Cerebral metastases in extrapulmonary cell carcinoma: implications for the use of prophylactic cranial irradiation","volume":"188","author":"Eckert","year":"2012","journal-title":"Strahlenther Onkol."},{"key":"2021051712135180000_60.10.1359.40","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.190827"},{"key":"2021051712135180000_60.10.1359.41","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-014-0025-7"},{"key":"2021051712135180000_60.10.1359.42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.zemedi.2016.02.002","article-title":"Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: a feasibility study","volume":"27","author":"Thorwarth","year":"2017","journal-title":"Z Med Phys."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.224543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:38:41Z","timestamp":1621283921000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.224543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,1]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.2967\/jnumed.118.224543"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.224543","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]}}}